Background: Continuous intrathecal drug delivery has been shown in open studies to improve pain and quality of life in those with intractable back pain who have had spinal surgery. There is limited data on long term effects and and even less for patients with mechanical back pain without prior spinal surgery.
Spinal cord stimulation reduces pain of critical ischaemia in patients with severe inoperable coronary artery and peripheral vascular disease by increasing microvascular flow. Patients with cardiac pacemaker may be denied a spinal cord stimulator (SCS) implant because of the risk of compromising pacemaker function by inhibition or reversion to asynchronous noise-pacing mode. We describe the management of a patient with an SCS implant for lower limb ischaemia who required a pacemaker. We suggest that with modern pacemakers it is safe to implant a spinal cord stimulator simultaneously with a pacemaker provided adequate precautions are taken to prevent interdevice interference.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.